Stock & Company Details
SpyGlass Pharma $SGP
Price:
46,691,331
33M
$684M
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
SGP technical indicators
Latest SpyGlass Pharma (SGP) technical indicators as of 2026-07-09: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
50.66 4.0%
MACD:
-0.07 27.6%
SMA 50:
$20.81 0.3%
SMA 200:
—
EMA 20:
$19.82 0.1%
Bollinger Bands:
21.81 / 17.01
Stochastic:
47.05 2.7%
ADX 14:
14.38 0.7%
ATR 14:
1.52 1.5%
CCI 20:
53.90 33.3%
OBV:
2.99M 4.4%
ROC 12:
3.77% 59.9%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.
Finance Bot
Ask your questions
Start by typing a question below.
